Lacerta Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Lacerta Therapeutics

Access the complete profile.

Lacerta Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	14189 Nw 129th Way Alachua, FL 32615

Note: Revenues for privately held companies are statistical evaluations.


Lacerta Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Lacerta Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Lacerta Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Lacerta Therapeutics Annual Revenue and Growth Rate

Lacerta Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Lacerta Therapeutics's revenues are gauged from an analysis of company filings.

Lacerta Therapeutics's Income Statement (based on Industry Averages)

Lacerta Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Lacerta Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
August 7, 2018	6	100%	$1 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Lacerta Therapeutics is developing and marketing. Lacerta Therapeutics doesn't have any recent trademark applications, indicating Lacerta Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
LACERTA THERAPEUTICS Gene therapy, namely, research and development services in the field of gene therapy	05/24/2018

See all trademarks and details in the Full Report.

Market Share of Lacerta Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Lacerta Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Lacerta Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
AXOGEN	Alachua, FL	100
LACERTA THERAPEUTICS	Alachua, FL	28
TUCKER-DAVIS TECHNOLOGIES	Alachua, FL	9
NEUROTRONICS	Alachua, FL	9
NORTH FLORIDA FOUNDATION FOR RESEARCH & EDUCATION	Gainesville, FL	7
FIREBIRD BIOMOLECULAR SCIENCES	Alachua, FL	5

Future Competition: Lacerta Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Lacerta Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)